Analysts from CGS-CIMB Research and UOB Kay Hian Research are recommending investors accumulate on Top Glove amid its stellar 1QFY2021 results as well as its Covid-19-related operational setbacks.

CGS-CIMB analyst Walter Aw has maintained his “add” recommendation albeit with a lower target price of RM8.90 ($2.93) from RM10 previously.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook